Literature DB >> 16256697

Inverse acyl phosph(on)ates: substrates or inhibitors of beta-lactam-recognizing enzymes?

M J Morrison1, N Li, R F Pratt.   

Abstract

Acyl phosph(on)ates represent a new class of inhibitors of beta-lactam-recognizing enzymes. Previously described members of this class were aroyl phosph(on)ates. These compounds have been shown to acylate and/or phosphylate the active site serine residue, leading to either transient or essentially irreversible inhibition [Li, N., and Pratt, R. F. (1998) J. Am. Chem. Soc.120, 4264-4268]. The present paper describes the synthesis and evaluation as inhibitors of an inverse pair of acyl phosph(on)ates that incorporate the amido side chain that represents a major substrate specificity determinant of these enzymes. Thus, N-(phenylacetyl)glycyl phenyl phosphate and benzoyl N-(benzyloxycarbonyl)aminomethyl phosphonate were prepared. The former of these compounds was found to be a substrate of typical class A and C beta-lactamases and of the DD-peptidase of Streptomyces R61; it thus acylates the active site serine. In contrast, the latter compound was an irreversible inhibitor of the above enzymes, probably by phosphonylation of the active site serine. With each of these enzymes therefore, the amido side chain rather than the acyl group dictates the orientation of the bound phosph(on)ate and thus the mode of reaction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 16256697     DOI: 10.1006/bioo.2001.1218

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  3 in total

1.  Intramolecular cooperativity in the reaction of diacyl phosphates with serine beta-lactamases.

Authors:  Sudipta Majumdar; R F Pratt
Journal:  Biochemistry       Date:  2009-09-08       Impact factor: 3.162

2.  Detection of an enzyme isomechanism by means of the kinetics of covalent inhibition.

Authors:  S A Adediran; Michael J Morrison; R F Pratt
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2021-06-02       Impact factor: 4.125

Review 3.  Development of new drugs for an old target: the penicillin binding proteins.

Authors:  Astrid Zervosen; Eric Sauvage; Jean-Marie Frère; Paulette Charlier; André Luxen
Journal:  Molecules       Date:  2012-10-24       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.